PTHS
AMEX Pelthos Therapeutics Inc.$20.15 ↑ +0.00 (+0.00%) Trading Up from the previous close of $20.15, $0.42 below the day’s high of $20.57
- YTD change
- -35.00%
- vs 20-day SMA
- -5.30%
- vs 200-day SMA
- -18.71%
Price ranges
Price & Performance
-2.74 (-11.91%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 62.9% away from all-time highs of $54.29
- PTHS is down 35% since the beginning of the year
- PTHS is down 29% over the past 12 months
- PTHS is down 10% over the past 1 month
- 7% of all PTHS investors are betting against PTHS
- Number of investors short PTHS has gone up 2% versus last month
PTHS reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -28.9%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -1.71%
- vs 8-day SMA
- -1.58%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform "Nitricil". Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.